Ali Sumera, Weiss Clifford R, Sinha Amitasha, Eng John, Mitchell Sally E
The Johns Hopkins Hospital, Division of Interventional Radiology, Baltimore, Maryland, USA
The Johns Hopkins Hospital, Division of Interventional Radiology, Baltimore, Maryland, USA.
Phlebology. 2016 Oct;31(9):603-9. doi: 10.1177/0268355516633380. Epub 2016 Mar 22.
We report a retrospective analysis of venous malformation patients treated with percutaneous sclerotherapy, describing their clinical manifestations, therapeutic outcomes and procedural complications.
We reviewed our Vascular Anomalies database for all patients who underwent percutaneous sclerotherapy for venous malformation between January 2005 and July 2011 and retrieved 186 patients, out of which 116 were included in the final analysis. The majority of patients were treated using 100% alcohol (72%) and the rest were treated with <100% alcohol, Sodium Tetradecyl Sulfate or combination of these therapies. The most common location was the lower extremity in 67 patients (58%), followed by the head and neck in 27 (23%) and the upper extremity in 11 (9%). Retrospective review of medical records was performed. Outcomes were classified on an improvement scale based on clinical therapeutic effects.
Two-hundred and forty-five sclerotherapy procedures were performed in 116 patients, of which 52 patients (45%) underwent a single procedure, 32 (28%) had two procedures and 32 (28%) underwent ≥3 procedures. Median follow-up period from the last procedure was 2.5 months (interquartile range of 2.0 to 6.75 months). Significant improvement was seen in 37 patients (32%), moderate improvement in 31 (27%), mild improvement in 20 (17%), no improvement in 21 (18%) and worse than before in 7 (6%) patients. Major post-procedural complications were nerve injuries in 6 patients (5%), deep vein thrombosis in 5 (4%), muscle contracture in 2 (2%), infection in 3 (3%), skin necrosis in 4 (3%) and other complications in 3 (3%).
Our study demonstrated that 76% of our patients with venous malformation had some level of improvement in symptoms with majority (72%) undergoing only one or two percutaneous sclerotherapy procedure/s. Although major complications occurred in 20% of the patients, majority (74%) of the complications either resolved spontaneously or were successfully treated.
我们报告了对接受经皮硬化治疗的静脉畸形患者的回顾性分析,描述了他们的临床表现、治疗结果和手术并发症。
我们查阅了血管畸形数据库中2005年1月至2011年7月期间接受经皮硬化治疗静脉畸形的所有患者,共检索到186例患者,其中116例纳入最终分析。大多数患者使用100%酒精治疗(72%),其余患者使用低于100%酒精、十四烷基硫酸钠或这些疗法的联合治疗。最常见的部位是下肢,共67例(58%),其次是头颈部27例(23%),上肢11例(9%)。对病历进行回顾性分析。根据临床治疗效果,将结果按改善程度进行分类。
116例患者共进行了245次硬化治疗,其中52例患者(45%)接受了单次治疗,32例(28%)接受了两次治疗,32例(28%)接受了≥3次治疗。最后一次治疗后的中位随访期为2.5个月(四分位间距为2.0至6.75个月)。37例患者(32%)有显著改善,31例(27%)有中度改善,20例(17%)有轻度改善,21例(18%)无改善,7例(6%)患者比治疗前更差。主要的术后并发症包括6例患者(5%)发生神经损伤,5例(4%)发生深静脉血栓形成,2例(2%)发生肌肉挛缩,3例(3%)发生感染,4例(3%)发生皮肤坏死,3例(3%)发生其他并发症。
我们的研究表明,76%的静脉畸形患者症状有一定程度的改善,大多数(72%)仅接受了一两次经皮硬化治疗。虽然20%的患者发生了主要并发症,但大多数(74%)并发症要么自行缓解,要么得到成功治疗。